Back
Open Access

Clinical characteristics, mortality outcomes and survival predictors of transthyretin cardiac amyloidosis in an Asian registry

Session: ePosters in myocardial disease (2)
Topic: Clinical
Speaker: Doctor V. Putri (Singapore, SG)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vebiona Kartini Prima Putri

National University Hospital, Singapore (Singapore)
1 presentation
0 follower

8 more presentations in this session

Effects of tafamidis on pacemaker therapy

Speaker: Doctor M. Figueiredo (Barreiro, PT)

Access
Abstract
Like
Thumbnail

A descriptive journey through the heart of transthyretin cardiac amyloidosis

Speaker: Doctor M. Rodrigues Simoes (Coimbra, PT)

Access
Abstract
Like
Thumbnail

Diagnostic value of the right ventricular wall thickness and free wall strain ratio in distinguishing hypertrophic cardiomyopathy and wild-type transthyretin cardiac amyloidosis

Speaker: Doctor E. Mata (Creixomil, PT)

Access
Abstract
Like
Thumbnail

Red-flags for cardiac amyloidosis in real life of an internal medicine department

Speaker: Doctor I. Fiteni Mera (Zaragoza, ES)

Access
Abstract
Like
Thumbnail

Associations between age and sex and cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy

Speaker: Doctor P. Gebrehiwet (South San Francisco, US)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in myocardial disease (2)

Speakers: Doctor V. Putri, Doctor M. Figueiredo, Doctor M. Rodrigues Simoes, Doctor E. Mata, Doctor I. Fiteni Mera...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources